Thomas Dorlo

Uppsala University is advertising two fully funded PhD positions in pharmacometrics with a strong global health focus at the Department of Pharmacy in Sweden. The positions begin in August 2026 and are linked to two research directions: tropical pharmacology (including malaria and leishmaniasis, with work on mass drug administration strategies and the ERC-funded TRANSPHORM project) and drug-resistant tuberculosis (embedded in the international consortia UNITE4TB and EX-DR TB). The projects use pharmacometric modelling and simulation , pharmacokinetics/pharmacodynamics (PK/PD) , systems pharmacology , and clinical trial data . Successful candidates will develop data-driven models for drug treatment, analyse clinical trial datasets, collaborate with international research groups, and publish and present findings. This is a research-intensive doctoral opportunity for applicants interested in infectious diseases, treatment optimization, and quantitative drug development. Eligibility highlights include an MSc in pharmacy, medicine, engineering, or a related field (or a Master in Pharmaceutical Modelling/Drug Development), with coursework in pharmacokinetics, physiology, pharmacology, modelling, and programming. Strong skills in R and NONMEM are expected, along with advanced English proficiency, teamwork, motivation, and structured research ability. Experience with clinical trials or global health research is considered a merit. The application requires a motivation letter, CV, diplomas and certificates, two recommendation letters, and any thesis or relevant supporting documents. The deadline is 15 May 2026 . Applications must be submitted through Uppsala University’s recruitment system.

Uppsala University is advertising an ERC-funded postdoctoral position in tropical pharmacology within the TRANSPHORM project. The project focuses on developing novel pharmacological strategies to interrupt transmission of visceral leishmaniasis and PKDL , combining clinical pharmacology , tropical medicine , vector biology , clinical trials , entomology , and pharmacometric modelling . The role is based at the Department of Pharmacy at Uppsala University, Sweden, with field visits and collaboration in India. The successful candidate will help design and coordinate sandfly challenge studies (xenodiagnosis), prepare a cluster randomized trial for transmission prevention, analyse complex datasets, and contribute to integrated modelling of pharmacokinetics, parasite dynamics, and entomological data. This is a fully funded postdoctoral appointment supported by the European Research Council . The position is temporary for 2 years with a possible 1-year extension , full-time. The project offers strong computational infrastructure, publication support, mentorship, and leadership opportunities, including mentoring PhD students. Eligibility highlights: applicants should hold a PhD in clinical pharmacology, drug development, infectious diseases, pharmacometrics, entomology, tropical medicine, or a related field; the degree should normally have been obtained within the last three years. Experience with clinical trials, international collaborations, structured project delivery, and excellent English communication is required. Skills in R/Python, NONMEM, transmission modelling, human challenge studies, qPCR, and entomological fieldwork are desirable. Application deadline: 2 August 2026. Applicants should submit a cover letter, CV, publication list, degree certificates, PhD thesis outline, short research statement, and two referees’ names plus recommendation letters via Uppsala University’s recruitment system.